---
title: "Daclizumab - Relapsing remitting multiple sclerosis"
sidebar: mydoc_sidebar
permalink: db00111-mesh-d020529-1.html
toc: false 
---


Path ID: `DB00111_MESH_D020529_1`
{% include image.html url="images/db00111-mesh-d020529-1.png" file="db00111-mesh-d020529-1.png" alt="db00111-mesh-d020529-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C096001 | daclizumab | Drug |
| UniProt:P01589 | Interleukin-2 receptor subunit alpha | Protein |
| GO:0005893 | interleukin-2 receptor complex | CellularComponent |
| GO:0038110 | interleukin-2-mediated signaling pathway | BiologicalProcess |
| GO:0050798 | Activated T cell proliferation | BiologicalProcess |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D020529 | Relapsing remitting multiple sclerosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Daclizumab | DECREASES ACTIVITY OF | Interleukin-2 Receptor Subunit Alpha |
| Interleukin-2 Receptor Subunit Alpha | PART OF | Interleukin-2 Receptor Complex |
| Interleukin-2 Receptor Complex | PARTICIPATES IN | Interleukin-2-Mediated Signaling Pathway |
| Interleukin-2-Mediated Signaling Pathway | POSITIVELY CORRELATED WITH | Activated T Cell Proliferation |
| Activated T Cell Proliferation | POSITIVELY CORRELATED WITH | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Relapsing Remitting Multiple Sclerosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00111](https://go.drugbank.com/drugs/DB00111)
  - [https://en.wikipedia.org/wiki/Daclizumab](https://en.wikipedia.org/wiki/Daclizumab)

Reference: 
  - [https://go.drugbank.com/drugs/DB00111](https://go.drugbank.com/drugs/DB00111)
  - [https://en.wikipedia.org/wiki/Daclizumab](https://en.wikipedia.org/wiki/Daclizumab)
